(Q37581209)

21 August 2017

1 reference

title

Cost-effectiveness perspectives in coronary heart disease (English)

1 reference

cost-effectiveness analysis

21 August 2017

1 reference

Goldman L

1

1 reference

PubMed ID

1968700

21 August 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

21 August 2017

American Heart Journal

1 reference

21 August 2017

119

1 reference

21 August 2017

3 Pt 2

1 reference

21 August 2017

733-9; discussion 739-40

1 reference

The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Myocardial infarction: a comparison between home and hospital care for patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Coronary care units. A perspective on their epidemiologic impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973-1974 and 1978-1979

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Thrombolysis in the treatment of acute transmural myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Reduction of prehospital, ambulance and community coronary death rates by the community-wide emergency cardiac care system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Paramedic programs and out-of-hospital cardiac arrest: II. Impact on community mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

The Recent Decline in Ischemic Heart Disease Mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

The community-based randomized trials of pharmacologic treatment of mild-to-moderate hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Mortality in cigarette smokers and quitters. Effect of base-line differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Relative impact of targeted versus populationwide cholesterol interventions on the incidence of coronary heart disease. Projections of the Coronary Heart Disease Policy Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Cost-effectiveness of screening strategies for left main coronary artery disease in patients with stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

The role of exercise testing in screening for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Care of patients with a low probability of acute myocardial infarction. Cost effectiveness of alternatives to coronary-care-unit admission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

A cost-effectiveness model for coronary thrombolysis/reperfusion therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

Mortality in patients of the Glasgow Blood Pressure Clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2805%2980054-7

10.1016/S0002-8703(05)80054-7

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

1968700